Collegium Pharmaceutical Inc (COLL)

[floblu14]

If you studied the various posters being presented this week in Las Vegas a new COLL concentration is prominent -

Healthcare Cost and Resource Use in Chronic Low Back Pain Patients Treated with Belbuca® and Buprenorphine Transdermal Patches: A Retrospective US Commercial Claims Analysis

Treatment Characteristics of Chronic Low Back Pain Patients Treated with Belbuca® and Buprenorphine Transdermal Patches: A Retrospective US Commercial Claims Analysis

Safety and Tolerability of Buprenorphine and Oral Schedule II Opioid Treatment in Chronic Low Back Pain Patients: A Retrospective US Commercial Claims Analysis

RESEARCH:

8 out of 10 people in the United States experience back problems at least one or more times. 50% of all Americans that are employed, about 80 million workers, claim to have back pain every year. Chronic back pain will develop in 5% of people that are struggling with mild symptoms at the onset.

What percentage of Americans will experience back pain in their lives?
One-half of all working Americans admit to having back pain symptoms each year. Back pain accounts for more than 264 million lost work days in one year—that's two work days for every full-time worker in the country. Experts estimate that up to 80% of the population will experience back pain at some time in their lives.

Is back pain becoming more common?
In 2020, low back pain (LBP) affected 619 million people globally and it is estimated that the number of cases will increase to 843 million cases by 2050, driven largely by population expansion and ageing (1).Jun 19, 2023

READ MORE:
https://www.google.com/search?q=how+prevalent+is+back+pain+in+us&rlz=1C5CHFA_enUS894US894&oq=how+prevalent+is+back+pain&aqs=chrome.0.69i59j69i57.12716j0j15&sourceid=chrome&ie=UTF-8